Eurofins Genomics Germany GmbH
Anzinger Strasse 7a
85560
Ebersberg bei München
Germany
Phone: +49 7531 8160 68
Fax: +49 8092 82 89 20 1
info-eu@eurofins.com
www.eurofinsgenomics.com
Get Directions
Eurofins Genomics is globally known for its innovative technologies in the life science arena including academic institutions, biotech and the pharmaceutical industry. We have established an outstanding team of more than 300 talented genomics experts and a broad range of technologies in the field of genomic services, forensics, agroscience, pharmaceutical, environmental, food and feed testing at fully automated production facilities around the world.
This unique team supports Eurofins Genomics' approach to offer best practices and flexibility for all clients - from academic institutions to large companies around the world. Our quality meets ISO 17025 and GLP/GCP standards.
Eurofins Genomics markets.
Pharma & Diagnostics
Eurofins Genomics has extensive experience in applying the different genetic analysis methods and techniques which are crucial for the entire drug development and production process:
- Preclinical phase through all phases of clinical trials (phases I, II and III)
- Quality control for production of biologicals
Comprehensive services are available for all customer study or project needs in the field of analysis, research and development.
Amongst others the Eurofins Genomics services portfolio covers DNA/RNA extraction for bio-banking, GLP-compliant genotyping and sequencing, biomarker analysis, residual DNA testing, adventitious agent testing via NGS or analysis of production strains and cell banks. These services are available from single sample analysis all the way through to the high throughput levels involving several thousand samples.
Agriculture & Food
Important traits in agricultural plants and livestock such as yield, drought resistance, pathogen resistance, feed efficiency and quality linked parameters are genetically encoded.
Eurofins Genomics agrigenomics services support:
- Plant breeding
- Farm animal & pet breeding
- Food production & authenticity testing
Eurofins Genomics provides a flexible, competent service with global reach, high industry standards and scalable capacity. One of the in-house experts will be assigned as the customers' project manager ensuring excellent support and communication.
Eurofins Genomics will find the perfect solution for customers' genomic characterisation and marker identification projects by integrating the latest technologies for sequencing and genotyping.
Industrial Biotechnology
Eurofins Genomics offers individual genomics solutions from the industry leading service portfolio.
These include:
- DNA & RNA extraction services
- Basic genomic, metagenomic & genetic characterisation
- Characterisation of genetic variability
- Residual host cell and pathogen DNA & RNA analysis
- Design and production of synthetic genes or gene evolution libraries
- GMO & genetic insert characterisation
- Assay design & validation
Research
From frequently used services such as DNA & RNA oligos and synthetic genes right through to genotyping, next generation sequencing and transcriptomics, Eurofins Genomics offers a broad portfolio of solutions and services for researchers:
- DNA & RNA Oligonucleotides
- Custom DNA Sequencing
- Next Generation Sequencing (NGS)
- Gene Synthesis & Molecular Biology
- Genotyping & Gene Expression Services
With the great deal of expertise and experience, Eurofins Genomics handles all types of research projects. The expert team employs more than 80 PhD's in all disciplines related to genomics to make customer's projects a success.
Accreditations:
Focusing on providing excellent customer support, together with highest quality services, Eurofins Genomics ensures to remain as one of the world’s leading genomic service providers. The company’s QM/QA System is ISO 13485 certified. As an ISO 17025 accredited DNA-testing laboratory approved by DAkkS, Eurofins Genomics also offers testing services that are compliant to the principles of Good Laboratory Practice (GLP) and Good Clinical Practice (GCP).